| 1 |
polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes
(78 times)
|
Ophthalmology
(14 times)
|
VEGF (17 times)
ODE (4 times)
CIDP (3 times)
|
1994 Ophthalmic findings in scleromyxedema.
|
| 2 |
M-protein, and skin changes
(46 times)
|
Neurology
(18 times)
|
VEGF (16 times)
CIDP (4 times)
ASCT (2 times)
|
1986 Multiple myeloma with polyneuropathy and coagulopathy. A case report of the polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin change (POEMS) syndrome.
|
| 3 |
plasma cell disorder, and skin changes
(9 times)
|
Nervous System Diseases
(3 times)
|
CD (4 times)
MCD (2 times)
UCD (2 times)
|
2006 Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
|
| 4 |
polymedication electronic monitoring system
(3 times)
|
Pharmacology
(1 time)
|
DDIs (1 time)
|
2012 Pattern of timing adherence could guide recommendations for personalized intake schedules.
|
| 5 |
polyneuropathy-organomegaly-endocrinopathy-M protein-skin changes
(3 times)
|
Neurology
(2 times)
|
MAG (1 time)
|
2006 Bilateral optic neuropathy associated with multiple myeloma.
|
| 6 |
protein and Skin changes syndrome
(3 times)
|
Neurology
(3 times)
|
DN (1 time)
POEMS-RODS (1 time)
RODS (1 time)
|
2008 [POEMS syndrome with plasmocytoma lytic bone lesion].
|
| 7 |
POEMS syndrome
(2 times)
|
Internal Medicine
(1 time)
|
iMCD (1 time)
|
2007 Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy.
|
| 8 |
Polyneuropathy, organomegaly, endocrinopathy, monoclonal syndrome
(2 times)
|
Atherosclerosis
(1 time)
|
---
|
2014 Complete heart block in a patient with POEMS syndrome: A case report.
|
| 9 |
Prevention of Early Menopause Study
(2 times)
|
Gynecology
(1 time)
|
CI (1 time)
GnRHa (1 time)
HR (1 time)
|
2014 Prevention of Early Menopause Study (POEMS): is it possible to preserve ovarian function by gonadotropin releasing hormone analogs (GnRHa)?
|
| 10 |
Programmable Otoacoustic Emissions Measurement System
(2 times)
|
Audiology
(2 times)
|
---
|
1993 External- and middle-ear factors affecting evoked otoacoustic emissions in neonates.
|
| 11 |
instrument--Parent Observation of Early Markers Scale
(1 time)
|
Pediatrics
(1 time)
|
ASD (1 time)
|
2011 Development and initial validation of a parent report measure of the behavioral development of infants at risk for autism spectrum disorders.
|
| 12 |
Monoclonal-protein and Skin Changes
(1 time)
|
Neurology
(1 time)
|
CIDP (1 time)
VEGF (1 time)
|
2020 Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
|
| 13 |
panoramic opto-electrical measurement and stimulation
(1 time)
|
Biology
(1 time)
|
---
|
2021 Enabling comprehensive optogenetic studies of mouse hearts by simultaneous opto-electrical panoramic mapping and stimulation.
|
| 14 |
paraproteinemic neuropathies
(1 time)
|
Neurology
(1 time)
|
CIDP (1 time)
CMT (1 time)
NPV (1 time)
|
2021 Is Perls Prussian Blue Stain for Hemosiderin a Useful Adjunct in the Diagnosis of Vasculitic Neuropathies?
|
| 15 |
patient-oriented eczema measure
(1 time)
|
Chemistry, Pharmaceutical
(1 time)
|
AD (1 time)
DLQI (1 time)
EASI (1 time)
|
2022 Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients.
|
| 16 |
patient-oriented evidence that matters
(1 time)
|
Primary Health Care
(1 time)
|
---
|
2001 POEMS (patient-oriented evidence that matters) spark discussion.
|
| 17 |
permeability factor is causative in Crow-Fukase
(1 time)
|
Neurology
(1 time)
|
CIDP (1 time)
CSF (1 time)
GBS (1 time)
|
1998 Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.
|
| 18 |
Polymeric Opto-Electro-Mechanical Systems
(1 time)
|
Biomedical Engineering
(1 time)
|
LD (1 time)
LLNL's (1 time)
|
2020 Design and microfabrication strategies for thin-film, flexible optical neural implant.
|
| 19 |
Polyneuropathy, organomegaly, endocrinopathy or edema, M-spike, and skin manifestations
(1 time)
|
Brain
(1 time)
|
---
|
2016 Paraneoplastic Progressive Vasculopathy as the Presenting Manifestation of Polyneuropathy, Organomegaly, Endocrinopathy or Edema, M-Spike, and Skin Manifestations: A Case Report.
|
| 20 |
polyneuropathy, organomegaly, endocrinopathy, M-protein, skin
(1 time)
|
Neurology
(1 time)
|
GBS (1 time)
|
2016 Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review.
|
| 21 |
polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes
(1 time)
|
Neurology
(1 time)
|
CIDP (1 time)
NCSs (1 time)
NIS (1 time)
|
2017 Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
|
| 22 |
Preschool Outdoor Environment Measurement Scale
(1 time)
|
Public Health
(1 time)
|
PA (1 time)
POD (1 time)
|
2014 Childcare outdoor renovation as a built environment health promotion strategy: evaluating the preventing obesity by design intervention.
|
| 23 |
Product Oriented Environmental Management System
(1 time)
|
Environmental Health
(1 time)
|
---
|
2006 POEMS: a case study of an Italian wine-producing firm.
|
| 24 |
Program for Outliers Elimination in Multidimensional Space
(1 time)
|
Biology
(1 time)
|
---
|
1988 POEMS: program for outliers elimination in multidimensional space.
|
A Search Service for Abbreviation / Long Form